SKIN vs. SIBN, AVNS, IRMD, TMCI, KIDS, CLPT, DCTH, SMLR, NPCE, and ZIMV
Should you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include SI-BONE (SIBN), Avanos Medical (AVNS), Iradimed (IRMD), Treace Medical Concepts (TMCI), OrthoPediatrics (KIDS), ClearPoint Neuro (CLPT), Delcath Systems (DCTH), Semler Scientific (SMLR), NeuroPace (NPCE), and ZimVie (ZIMV). These companies are all part of the "medical equipment" industry.
Beauty Health vs.
Beauty Health (NASDAQ:SKIN) and SI-BONE (NASDAQ:SIBN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, community ranking, risk and valuation.
93.3% of Beauty Health shares are held by institutional investors. Comparatively, 98.1% of SI-BONE shares are held by institutional investors. 41.0% of Beauty Health shares are held by company insiders. Comparatively, 3.9% of SI-BONE shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Beauty Health has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, SI-BONE has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500.
SI-BONE has lower revenue, but higher earnings than Beauty Health. SI-BONE is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.
SI-BONE received 132 more outperform votes than Beauty Health when rated by MarketBeat users. Likewise, 68.80% of users gave SI-BONE an outperform vote while only 45.98% of users gave Beauty Health an outperform vote.
Beauty Health currently has a consensus price target of $2.55, indicating a potential upside of 100.00%. SI-BONE has a consensus price target of $24.50, indicating a potential upside of 39.44%. Given Beauty Health's higher possible upside, equities analysts clearly believe Beauty Health is more favorable than SI-BONE.
Beauty Health has a net margin of -8.11% compared to SI-BONE's net margin of -23.82%. SI-BONE's return on equity of -22.51% beat Beauty Health's return on equity.
In the previous week, SI-BONE had 14 more articles in the media than Beauty Health. MarketBeat recorded 27 mentions for SI-BONE and 13 mentions for Beauty Health. Beauty Health's average media sentiment score of 1.06 beat SI-BONE's score of 0.31 indicating that Beauty Health is being referred to more favorably in the media.
Summary
SI-BONE beats Beauty Health on 10 of the 18 factors compared between the two stocks.
Get Beauty Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Beauty Health Competitors List
Related Companies and Tools
This page (NASDAQ:SKIN) was last updated on 3/4/2025 by MarketBeat.com Staff
Free SKIN Stock Alerts